Latest Cancer News
US woman, 39, told she never had cancer after undergoing aggressive chemotherapy
The latest headlines from our reporters across the US sent straight to…
Response to Larotrectinib in NTRK+ Thyroid Cancer Differs By Subtype
Lori J. Wirth, MD, associate professor of medicine at Harvard Medical School…
Researchers discover a mechanism that could improve platinum-based cancer therapy
Researchers have identified a protein that, when targeted, enables cisplatin-resistant cancer cells…
Mapping the evolution of urinary tract cancer cells
Researchers at Weill Cornell Medicine have performed the most comprehensive analysis to…
Genetic risk of new cancers among childhood cancer survivors
Genetics may one day help inform a childhood cancer survivor’s risk of…
A Look at the Latest Advancements in Thyroid Cancer Treatment
Lori J. Wirth, MD, associate professor of medicine at Harvard Medical School…
New Potential Targets Give Hope for Thyroid Cancer Treatment
Thyroid cancer of a woman, medically 3D illustration, front view: © Axel…
Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission
Drugs and reagentsRuxolitinib (Ruxo, Cat: T1829), Mdivi-1 (Cat: T1907), STX-0119 (Cat: T60160),…
Emerging roles of circular RNAs in regulating the hallmarks of thyroid cancer
Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia…